Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05957302Completed
Randomised, single-blind trial of ketamine in septic shock (2 arms), sponsored by Cairo University. Primary endpoint: 6-minutes Percentage Change in Cardiac Output. Started Aug 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05957302.